PDT Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-11,061
| Closed | -$704K | – | 532 |
|
|
2016
Q3 | $704K | Sell |
11,061
-89,607
| -89% | -$5.7M | 0.04% | 343 |
|
|
2016
Q2 | $7.49M | Sell |
100,668
-10,901
| -10% | -$811K | 0.59% | 19 |
|
|
2016
Q1 | $7.45M | Buy |
111,569
+24,686
| +28% | +$1.65M | 0.47% | 27 |
|
|
2015
Q4 | $5.88M | Buy |
86,883
+50,976
| +142% | +$3.45M | 0.81% | 9 |
|
|
2015
Q3 | $1.92M | Buy |
35,907
+2,510
| +8% | +$134K | 0.04% | 473 |
|
|
2015
Q2 | $2.1M | Buy |
33,397
+1,675
| +5% | +$105K | 0.06% | 415 |
|
|
2015
Q1 | $1.53M | Buy |
+31,722
| New | +$1.53M | 0.04% | 557 |
|
|
2014
Q4 | – | Sell |
-31,066
| Closed | -$911K | – | 885 |
|
|
2014
Q3 | $911K | Buy |
31,066
+4,368
| +16% | +$128K | 0.02% | 705 |
|
|
2014
Q2 | $1.04M | Buy |
+26,698
| New | +$1.04M | 0.03% | 684 |
|
|
2013
Q4 | – | Sell |
-60,765
| Closed | -$1.64M | – | 930 |
|
|
2013
Q3 | $1.64M | Buy |
+60,765
| New | +$1.64M | 0.04% | 578 |
|